Navigation Links
Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors
Date:12/12/2007

Leonard Osser, Former CEO, Will Continue Serving as Chairman of the Board

LIVINGSTON, N.J., Dec. 12 /PRNewswire-FirstCall/ -- Milestone Scientific, Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the Board of Directors has named Joe Martin, Chief Executive Officer of the Company's medical division, as the new CEO of the Company and a member of its Board of Directors, effective January 1, 2008. As CEO, Martin replaces Leonard Osser, who will continue serving as the Chairman of the Board.

"We are very pleased that Joe has agreed to become Milestone's CEO and the newest addition to our Board of Directors," stated Osser. "Since Joe's arrival, he has been instrumental in directing and effecting positive changes in Milestone's operations. Given our longstanding belief that Milestone's ultimate success will stem from maximizing opportunities for our patented CompuFlo(R) technology in the medical arena, coupled with Joe's level of experience and expertise earned as an executive at Bayer and Abbott, there is simply no question that he is the ideal choice to assume leadership of our Company."

Martin has served as CEO of Milestone Medical since joining the Company in May 2007. Previously, he served as President of the Diabetes Care Division (DCD) at Bayer Healthcare, as well as a member of the Bayer HealthCare Executive Committee. From 1992 through 2005, Martin rose through the ranks at Bayer in managerial posts that included Senior Vice President and General Manager, Self-Testing Business Segment; Country Manager -- United Kingdom and Ireland; and Vice President, Marketing -- Immunodiagnostic Business Unit. From 1980 until 1992, Martin held various sales, marketing and general management roles of increasing responsibility, both domestically and internationally, at Abbott Laboratories -- Diagnostic Division. Martin is a graduate of the University of Houston, where he earned a Bachelors of
'/>"/>

SOURCE Milestone Scientific, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Purple: The Hottest Color for Fall in Shoes, Handbags and Martinis
2. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
3. Eric Rowinsky, M.D. and Martin Cannon Join Tapestry Board of Directors
4. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
5. William Moore Appointed to IRIDEX Board of Directors
6. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
7. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
8. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
9. James B. Hawkins Appointed to IRIDEX Board of Directors
10. Bryan R. Rogers Appointed President of Far West Division
11. Catholic Health Association Disappointed by Failure to Override SCHIP Veto

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...wswire/ -- Welcome to syngo® .plaza(1),...utine from Siemens Healthcare. As the first ... from Siemens where 2D, 3D, and 4D reading come ... to change the way multimodality images are read t...e 95th Scientific Assembly and Annual Meeting of t...
(Date:11/27/2009)... GSI Group Inc. (Pink Sh...on technology products and semiconductor systems, ...any,s shareholders has been scheduled for Friday, ...ing will be announced in due course. As previousl...tice from Stephen Bershad, a holder of greater tha...
(Date:11/27/2009)... Preventing disease is ...tely every year, new vaccines are being added to a...oost immunity for the same period of time? And, if...o keep immunity strong? ,, In this month,s is...demy of Pediatrics, Michael Pichichero MD, Directo...
(Date:11/27/2009)... medical, economic burdens, study predicts , ...ber of people with diabetes in the United States i... study predicts. , That would bring the total b...se, up from 23.7 million today. , , At the same ...ll triple, the study also warns, rising from an es...
(Date:11/27/2009)...interactive anatomy education apps from Modality a... sciences learning opportunities for iPhone and iP...cus) November 27, 2009 -- Modality, Inc. and Lip...f Wolters Kluwer Health, today announced the avail... App Store. Clemente’s Anatomy, Rohen’...
Breaking Medicine News(10 mins):Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...nography (CTC) depicts cancers and other clinicall...th standard colonoscopy and at very little additio... of Radiology. "The chance of finding cancer...fairs Medical Center and associate professor and V...
...esus monkeys with macular degeneration and humans/...rts science portal www.eurekalerts.org. Age-r...f blindness in older adults, yet researchers are s...rsity of Florida and other researchers, studied se...
...tem cell therapy can be used successfully to treat...niversity School of Medicine had showed that it is...ch a way. In just two months, stem cells ha...rcent to 75 percent. The findings are to b...
...at Leishmania parasite utilizes mannose for their ...olism which requires glucose. Associate Prof...m Bio21 Institute at the University of Melbourne h...r their metabolism and growth and it was found tha...
...ad presented a report saying that wearing high hee...ntal disorders like schizophrenia etc. Jarl F...nse their calves in a way that normal walking neve...During walking, synchronized stimuli from mechanor...
...t factories may be at a heightened risk from hyper...of work. Scientists from the Desert Medicine R...blood pressure of workers in two salt milling fact... grinding, milling and packing salt and those who ...
Other Medicine News:Health News:Virtual Colonoscopy May Be Better Than Real-time Colonoscopy 2Health News:Monkeys offer genetic clues to adult blindness 2Health News:Stem Cell Therapy For Treating Heart Attacks 2Health News:Metabolism cycle of Kala-Azar parasite revealed 2Health News:Wearing High Heels May Be Dangerous To Health, 2Health News:Wearing High Heels May Be Dangerous To Health, 3Health News:Inhaling Salt Can Lead To Hypertension 2
(Date:11/25/2009)..., , MOUNTAIN VIEW, Calif., Nov. 25 /PRNewsw... Phase II/III clinical data from the Company,s PRO...aluation in Crohn,s disease Trial) of Traficet-EN(... Crohn,s disease demonstrated clinical efficacy wi...he study demonstrated evidence of clinical efficac...
(Date:11/24/2009)..., , PITTSBURGH, Nov. 24 ... have been in coma for 23 years following an auto ...uring that time and was the subject of a Good Morn...red in the segment to illustrate how people with L...communication. ,, WHEN: Good Morning America -...
(Date:11/24/2009)..., , MADISON, N.J., Nov. 24 /PRNewswire-...: DGX ), the world,s leading provider of diagnos...hat it is scheduled to speak at the 21st Annual Pi.... The presentation is scheduled for Wednesday, De...ring the conference, the company will reaffirm its...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Bionovo Announces Pricing of Securities Offering 58766 1Bionovo Announces Pricing of Securities Offering 58766 2Bionovo Announces Pricing of Securities Offering 58766 3Yongye International Announces 2010 2012 Strategic Plan 14335 1Yongye International Announces 2010 2012 Strategic Plan 14335 2Yongye International Announces 2010 2012 Strategic Plan 14335 3Yongye International Announces 2010 2012 Strategic Plan 14335 4Yongye International Announces 2010 2012 Strategic Plan 14335 5Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 1Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 2
...T High-Risk Registry Data Shows Improved Symptomat...tients Treated with the MitraClip(R) System , , O...repair using the MitraClip(R) system in symptomati...al regurgitation (FMR) improves patient clinical s... 12-month data from the high-risk registry arm of ...
...RK, March 27 The Michael J. Fox Foundation announ... total to seven research teams working to improve ...nding was awarded under the Foundation,s Improvin...the Brain . The program is designed to address two...tive treatments for Parkinson,s disease: the need ...
Other Medicine Technology:MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up 2MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up 3Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinson's Disease 2
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: